###
中国临床研究:2025,38(8):1224-1226,1231
本文二维码信息
码上扫一扫!
经皮内镜椎间孔入路治疗高位椎间盘突出症的临床疗效
(南京医科大学附属淮安第一医院骨科, 江苏 淮安 223001)
Clinical efficacy of percutaneous endoscopic foraminal approach in the treatment of upper lumbar disc herniation
(Department of Orthopedics,The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University,Huai'an,Jiangsu 223001,China)
摘要
本文已被:浏览 219次   下载 153
投稿时间:2024-09-29   网络发布日期:2025-08-20
中文摘要: 目的 探讨经皮内镜椎间孔入路治疗高位椎间盘突出症(ULDH)患者的临床疗效,为ULDH患者选择最佳治疗方案提供参考。方法 回顾性分析2020年1月至2024年5月南京医科大学附属淮安第一医院行经皮内镜椎间孔入路治疗的27例ULDH患者的临床资料。其中,男21例,女6例,年龄21~79(57.33±15.32)岁。L2~3节段9例,L3~4节段18例。术前、术后第1天、术后第1个月及末次随访时,采用视觉模拟评分法(VAS)评估腰腿痛程度,采用Oswestry功能障碍指数(ODI)和日本骨科协会评估治疗(JOA)评分来评估腰椎功能改善情况,末次随访采用改良MacNab 功能标准评定疗效,记录术后并发症以及术后复发情况等。结果 所有患者均顺利完成手术,随访时间3~24个月,随访期间无硬膜囊撕裂、神经损伤等并发症。腰痛VAS评分(F=148.989,P<0.01)、下肢痛 VAS 评分(F=154.236,P<0.01)、腰椎 JOA 评分(F=555.144,P<0.01)、ODI 指数(F= 1 699.511,P<0.01)时间主效应均有统计学意义。与术前相比,术后 1 天、术后 1 个月及末次随访时以上四指标均有显著改善(P<0.05)。末次随访时,根据改良的MacNab评分标准,优20例,良5例,可2例,优良率为 92.6%。结论 经皮内镜椎间孔入路治疗ULDH临床疗效显著,具有创伤小、出血少、术后恢复快的特点,值得临床推广应用,但是要选择合适病例。
Abstract:Objective To explore the clinical efficacy of percutaneous endoscopic transforaminal approach in the treatment of patients with upper lumbar intervertebral disc herniation(ULDH), and to serve as a reference for selecting the optimal treatment plan for ULDH patients. Methods A retrospective analysis was conducted on the clinical data of 27 patients with ULDH treated by percutaneous endoscopic transforaminal approach at the Affiliated Huai'an First People's Hospital of Nanjing Medical University from January 2020 to May 2024. There were 21 male patients and 6 female patients,aged from 21 to 79(57.33 ± 15.32)years. The L2 - 3 segment was involved in 9 cases,and the L3 - 4 segment was involved in 18 cases. Preoperative, 1 - day postoperative,1 - month postoperative,and last follow - up evaluations included assessment of low back and leg pain using the Visual Analog Scale(VAS),and evaluation of lumbar function improvement using the Oswestry Disability Index(ODI)and Japanese Orthopaedic Association(JOA)scores. The modified MacNab functional criteria were used to assess the outcome at the last follow-up. Postoperative complications and recurrence were also recorded. Results All patients successfully completed the surgery,with a follow-up period ranging from 3 to 24 months. During the follow-up period,no complications such as dural sac tear or nerve injury occurred. The main effects of time on VAS for low back pain(F=148.989,P<0.01),VAS for lower limb pain(F=154.236,P<0.01),JOA lumbar score(F=555.144,P<0.01),and ODI(F=1 699.511,P<0.01)were statistically significant. Compared with preoperative values,significant improvements were observed in all four indicators on 1-day postoperative,1-month postoperative,and last follow-up(P<0.05). At the last follow-up,according to the modified MacNab criteria,20 cases were rated as excellent,5 as good,and 2 as fair,with an excellent-to-good rate of 92.6%.Conclusion The percutaneous endoscopic transforaminal approach for the treatment of ULDH shows significant clinical efficacy,with advantages such as minimal trauma,low blood loss,and rapid postoperative recovery. It is worthy of clinical promotion and application,but suitable case selection is necessary.
文章编号:     中图分类号:R681.5    文献标志码:A
基金项目:
附件
引用文本:
朱海,徐用亿,王帅,季峰.经皮内镜椎间孔入路治疗高位椎间盘突出症的临床疗效[J].中国临床研究,2025,38(8):1224-1226,1231.

用微信扫一扫

用微信扫一扫